Contract 75A50124F61011
Seqirus Inc · Department Of Health And Human Services · February 20, 2024
Seqirus Inc was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on February 20, 2024 for $951,000 of work in biological product (except diagnostic) manufacturing. Performance is in Holly Springs, NC. This is a task or delivery order issued under parent IDIQ 75A50122D00004. The contract has been modified 9 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 25, 2026.
Contract details
- PIID
- 75A50124F61011
- Parent IDIQ
- 75A50122D00004
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 325414 · Biological Product (Except Diagnostic) Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Holly Springs, NC
- First action
- February 20, 2024
- Latest action
- March 25, 2026
Description
THE PURPOSE OF THIS TASK ORDER IS TO PERFORM A SHORT-TERM PHYSICAL AND CHEMICAL COMPATIBILITY (PC) STUDY ON THE ANTIGEN AND MF59 DOSING COMBINATIONS TO SUPPORT OF THE INTENDED HOLD TIME FOR THE BARDA
Modification timeline
-
March 25, 2026Mod P00002THE PURPOSE OF THIS TASK ORDER IS TO PERFORM A SHORT-TERM PHYSICAL AND CHEMICAL COMPATIBILITY (PC) STUDY ON THE ANTIGEN AND MF59 DOSING COMBINATIONS TO SUPPORT$0
-
December 17, 2025Mod P00001ACQUISITION OF EGG-BASED INFLUENZA MASTER AND WORKING SEED LOTS DERIVED FROM A/AMERICAN WIGEON/SOUTH CAROLINA/22-000345-001/2021 (H5N1) CANDIDATE VACCINE VIRUS$0
-
February 19, 2025Mod P00004THE PURPOSE OF THIS TASK ORDER IS TO PROCURE SERVICES FOR STORAGE AND STABILITY VACCINE BULK LOTS FROM PRIOR CONTRACTS FOR U.S. DEPARTMENT OF DEFENSE (DOD) UNDE$121.7K
-
November 22, 2024Mod P00001THE PURPOSE OF THIS NO COST BILATERAL MODIFICATION IS TO EXTEND THE PERIOD OF PERFORMANCE FROM DECEMBER 3, 2024 TO MARCH 14, 2025.$0
-
September 19, 2024Base awardTHE PURPOSE OF THIS TASK ORDER IS TO PERFORM A SHORT-TERM PHYSICAL AND CHEMICAL COMPATIBILITY (PC) STUDY ON THE ANTIGEN AND MF59 DOSING COMBINATIONS TO SUPPORT$23.7K
-
September 4, 2024Base awardACQUISITION OF EGG-BASED INFLUENZA MASTER AND WORKING SEED LOTS DERIVED FROM A/AMERICAN WIGEON/SOUTH CAROLINA/22-000345-001/2021 (H5N1) CANDIDATE VACCINE VIRUS$681.0K
-
August 20, 2024Mod P00003THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE AND FULLY FUND OPTION 6 WITH A PERIOD OF PERFORMANCE OF 8/22/2024-5/21/2025. THE TOTAL OBLIGATED AMOUNT IS INCR$62.0K
-
August 12, 2024Mod P00002THE PURPOSE OF THIS ADMINISTRATIVE MODIFICATION IS TO UPDATE ARTICLE G.2. CONTRACTING OFFICER'S REPRESENTATIVE (COR). BEZA SEYOUM REPLACES LAKSHMI JAYASHANKAR A$0
-
April 22, 2024Mod P00001THE PURPOSE OF THIS MODIFICATION IS AS FOLLOWS: REVISE THE POP OF OPTION PERIOD 1 FROM 5/22/2024 - 5/21/2025 (12-MONTHS) TO 5/22/2024 - 3/21/2025 (10-MONTHS)$46.8K
-
February 20, 2024Base awardTHE PURPOSE OF THIS TASK ORDER IS TO PROCURE SERVICES FOR STORAGE AND STABILITY VACCINE BULK LOTS FROM PRIOR CONTRACTS FOR U.S. DEPARTMENT OF DEFENSE (DOD) UNDE$15.7K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Bio-Rad Laboratories, Inc. | Department Of Health And Human Services | March 31, 2026 | $20.6K |
| Georgia Tech Research Corp | Department Of Health And Human Services | March 28, 2026 | $145.8K |
| Seqirus Inc | Department Of Health And Human Services | March 24, 2026 | $0 |
| Battelle Memorial Institute | Department Of Health And Human Services | March 19, 2026 | $2.80M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 19, 2026 | $53.21M |
| Life Technologies Corporation | Department Of Health And Human Services | March 17, 2026 | $18.9K |
Top contractors in NAICS 325414
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Pfizer Inc | 3 | $15.27B |
| 2 | Sanofi Vaccines Us Inc. | 606 | $9.38B |
| 3 | Regeneron Pharmaceuticals Inc | 1 | $5.57B |
| 4 | Merck Sharp & Dohme Corp. | 56 | $3.99B |
| 5 | Emergent Biodefense Operations Lansing Llc | 16 | $3.34B |
| 6 | Merck Sharp & Dohme Llc | 15 | $3.33B |
| 7 | Pfizer Inc. | 25 | $3.11B |
| 8 | Glaxosmithkline Holdings (Americas) Inc. | 109 | $2.24B |
| 9 | Modernatx, Inc. | 1 | $1.75B |
| 10 | Bavarian Nordic A/S | 1 | $1.01B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50124F61011?
Contract 75A50124F61011 is a federal contract awarded to Seqirus Inc by Department Of Health And Human Services on February 20, 2024 for $951,000 of work classified under BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING. It has been modified 9 times since the base award.
Who won contract 75A50124F61011?
Seqirus Inc won contract 75A50124F61011 from Department Of Health And Human Services.
How much is contract 75A50124F61011 worth?
Contract 75A50124F61011 has obligated $951,000 to date.